EUA

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Sunday, January 29, 2023
Person, COVID 19, News, COVID, Patient, FDA, EUA, Steve Berman (lawyer), Inc., Pharmaceutical industry, Verus Pharmaceuticals

VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.

Key Points: 
  • VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
  • Investors learned the truth on Nov. 9, 2022, when Veru announced that the FDA advisory committee (“AdCom”) voted against approving sabizabulin under the agency’s EUA pathway.
  • If you invested in Veru and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Veru should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Veru Inc. (VERU)

Retrieved on: 
Thursday, January 26, 2023
COVID-19, Court, GPM, Suite, FDA, EUA, News, Pharmaceutical industry, Verus Pharmaceuticals

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Veru common stock during the Class Period, you may move the Court no later than February 6, 2023 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, January 24, 2023
Telephone, NeoGenomics, Abuse, People's Law Office, NGS, Suite, Class, Old Navy, EUA, Investment, Fraud, Law, Security (finance), Risk management

BENSALEM, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, January 24, 2023
Steiner, Fast Track, COVID-19, Fast track (FDA), NDA, Defendant, FDA, Plaintiff, Aerospace, News, Standard of care, Breast, Generac Holdings, SPA, Ink, P.C, Bankruptcy, Old Navy, Death, Infection, Gap Inc., Complaint, GPS, Trial of the century, Security (finance), Market share, Gap, Principle, Electricity, Safety, Failure, NYSE, Health minister, Patient, EUA, Mortality, Form 10-Q, Maintenance, Prostate cancer, Holding company, Renewable energy, Animal, Audit, Pharmaceutical industry, Singularity, Verus Pharmaceuticals

Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.

Key Points: 
  • Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.
  • In addition, the complaint alleges that Defendants overstated the Company's earnings throughout the Class Period.
  • Throughout the Class Period, numerous consumers filed complaints with regulators, and Generac's channel partners informed the Company of the SnapRS defect.
  • As a result of Defendants misrepresentations and omissions, Generac common stock traded at artificially inflated prices during the Class Period.

VERU INC. (NASDAQ: VERU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Veru Inc. (NASDAQ: VERU)

Retrieved on: 
Monday, January 23, 2023
Breast, Steiner, Prostate cancer, Safety, Fast Track, Trial of the century, COVID-19, The Legal 500, Fast track (FDA), Advertising, Court, Health minister, NDA, Labour government, Patient, FDA, District court, EUA, Investment, Mortality, Aerospace, Infection, Death, Prostate Cancer Foundation, News, Tobacco, Security (finance), Pharmaceutical industry, Verus Pharmaceuticals

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of Veru Inc. (“Veru” or the “Company”) (NASDAQ: VERU) between May 11, 2022 and November 9, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of Florida and alleges violations of the Securities Exchange Act of 1934.
  • Veru is primarily an oncology-based biopharmaceutical company that develops drugs for the management of breast and prostate cancers.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

VERU 2-WEEK DEADLINE ALERT: Hagens Berman Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Fraud Class Action

Retrieved on: 
Monday, January 23, 2023
Person, COVID 19, News, COVID, Patient, SAN, FDA, EUA, Steve Berman (lawyer), Pharmaceutical industry, Verus Pharmaceuticals

SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .
  • VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
  • Investors learned the truth on Nov. 9, 2022, when Veru announced that the FDA advisory committee (“AdCom”) voted against approving sabizabulin under the agency’s EUA pathway.
  • If you invested in Veru and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

DEADLINE ALERT for GNRC, GPS, VERU, and NEO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, January 23, 2023
NeoGenomics, Generac Holdings, Abuse, Complaint, NGS, Suite, Defendant, Marcus Annius Verus Caesar, EUA, Investment, Fraud, Law, Mail, Holding company, Risk management

LOS ANGELES, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

GNRC, VERU & SPPI Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Firm, Reminds Investors of Deadlines and to Actively Participate

Retrieved on: 
Monday, January 23, 2023
Complaint, Safety, HER2, Court, NDA, Patient, Defendant, FDA, EUA, Pharmaceutical industry

You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.

Key Points: 
  • You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Generac, Veru, Gap, and Singularity and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, January 19, 2023
News, Fast track (FDA), Defendant, Gap Inc., Health minister, EUA, Death, Maintenance, Steiner, Bankruptcy, Mortality, SPA, Plaintiff, FDA, NYSE, Fast Track, Generac Holdings, P.C, GPS, Infection, Market share, Security (finance), Prostate cancer, Failure, Form 10-Q, Aerospace, COVID-19, Gap, Standard of care, Trial of the century, Safety, Breast, NDA, Complaint, Ink, Patient, Old Navy, Principle, Electricity, Holding company, Renewable energy, Animal, Audit, Pharmaceutical industry, Verus Pharmaceuticals, Singularity

Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.

Key Points: 
  • Generac's solar offering, called the PWRcell, is a battery-based system that stores and manages electricity generated from solar panels.
  • In addition, the complaint alleges that Defendants overstated the Company's earnings throughout the Class Period.
  • Throughout the Class Period, numerous consumers filed complaints with regulators, and Generac's channel partners informed the Company of the SnapRS defect.
  • As a result of Defendants misrepresentations and omissions, Generac common stock traded at artificially inflated prices during the Class Period.

DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Wednesday, January 18, 2023
NGS, EUA, Law, Class, NeoGenomics, Telephone, Suite, Old Navy, Fraud, Abuse, Investment, People's Law Office, Security (finance), Risk management

BENSALEM, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith